drugset / Trial / NCT03436472

Dexmedetomidine and 5-year Outcome in Elderly Patients After Surgery

NCT03436472 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Delirium is a frequent postoperative complication. Its occurrence is associated with worse long-term outcomes. In a previous randomized controlled trial, prophylactic low-dose dexmedetomidine infusion during the early postoperative period decreased the incidence of delirium in elderly patients after surgery. The purpose of this 5-year follow-up study is to evaluate whether prophylactic low-dose dexmedetomidine infusion can improve the 5-year outcomes in elderly patients recruited in the previous randomized controlled trial.

Timeline

Start
2017-06-01
Primary completion
2019-01-08
Completion
2019-04-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.1 ug/kg —

Indications